Skip to main content
OpenTrials
Completed

NCT Number: NCT01042119

Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

The neurotoxin Botox (botulinum neurotoxin type A) is shown to be effective in the treatment of therapy refractory overactive bladder syndrome. Our data suggests a longer during efficacy than known from the use in striated muscle.

The aim of our study is to analyze short- and longterm efficacy after Botox treatment and to evaluate risk factors for non-responders and side effects such as urinary retention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

University Hospital of Zurich, Clinic for Gynaecology

Zurich, 8091, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • intravesical treatment with Botox at our clinic

Treatment and study plan

Primary outcomes

  1. duration of effect of Botox

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Official study title

Short- and Longterm Results After Intravesical Injection of Botulinum Neurotoxin Type A for Treating Therapy Refractory Overactive Bladder in Females - a Retrospective Study

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jan 5, 2010
Registry last updated
Jun 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.